Skip to main content
. 2021 Dec 15;7(3):e002025. doi: 10.1136/rmdopen-2021-002025

Table 5.

Osteoarthritis CT grades in NP and non-NP patients

NP (n=24) Non-NP (n=48) P value
OACT grades
Index knee n (%) 0.010*
 0 7 (29.2) 4 (8.3)
 1 9 (37.5) 10 (20.8)
 2 7 (29.2) 22 (45.8)
 3 1 (4.2) 12 (25.0)
Contralateral knee n (%) 0.199*
 0 4 (16.7) 4 (8.3)
 1 14 (58.3) 20 (41.7)
 2 5 (20.8) 16 (33.3)
 3 1 (4.2) 8 (16.7)
Index patellofemoral n (%) 0.409
 0 6 (25.0) 6 (12.5)
 1 10 (41.7) 18 (37.5)
 2 3 (12.5) 12 (25.0)
 3 5 (20.8) 12 (25.0)
Contralateral patellofemoral n (%) 0.329
 0 7 (14.6) 7 (29.2)
 1 9 (37.5) 15 (31.3)
 2 4 (16.7) 14 (29.2)
 3 4 (16.7) 12 (25.0)
Left hip n (%) 0.638*
 0 16 (66.7) 31 (64.6)
 1 7 (29.2) 16 (33.3)
 2 1 (4.2) 0 (0.0)
 3 0 (0.0) 1 (2.1)
Right hip n (%) 0.868*
 0 14 (58.3) 28 (58.3)
 1 7 (29.2) 16 (33.3)
 2 3 (12.5) 4 (8.3)
 3 0 (0.0) 0 (0.0)
Left ankle n (%) 0.268*
 0 21 (87.5) 33 (68.8)
 1 3 (12.5) 13 (27.1)
 2 0 (0.0) 0 (0.0)
 3 0 (0.0) 0 (0.0)
Right ankle n (%) 0.420*
 0 20 (83.3) 31 (64.6)
 1 4 (16.7) 13 (27.1)
 2 0 (0.0) 2 (4.2)
 3 0 (0.0) 0 (0.0)
Left acromioclavicular n (%) 0.705*
 0 11 (45.8) 16 (33.3)
 1 5 (20.8) 14 (29.2)
 2 2 (8.3) 3 (6.3)
 3 6 (25.0) 15 (31.3)
Right acromioclavicular n (%) 0.023
 0 11 (45.8) 7 (14.6)
 1 6 (25.0) 13 (27.1)
 2 1 (4.2) 8 (16.7)
 3 6 (25.0) 20 (41.7)
Left glenohumeral n (%) 0.480*
 0 21 (87.5) 36 (75.0)
 1 2 (8.3) 10 (20.8)
 2 1 (4.2) 1 (2.1)
 3 0 (0.0) 0 (0.0)
Right glenohumeral n (%) 0.340*
 0 19 (79.2) 38 (79.2)
 1 2 (8.3) 8 (16.7)
 2 3 (12.5) 2 (4.2)
 3 0 (0.0) 0 (0.0)
C1 n (%) 0.786*
 0 1 (4.2) 2 (4.2)
 1 5 (20.8) 7 (14.6)
 2 7 (29.2) 11 (22.9)
 3 11 (45.8) 28 (58.3)
C1 facet n (%) 0.943
 0 3 (12.5) 6 (12.5)
 1 5 (20.8) 11 (22.9)
 2 6 (25.0) 9 (18.8)
 3 10 (41.7) 22 (45.8)
C2 n (%) 0.083
 0 6 (25.0) 8 (16.7)
 1 3 (12.5) 12 (25.0)
 2 10 (41.7) 9 (18.8)
 3 5 (20.8) 19 (39.6)
C2 facet n (%) 0.676
 0 8 (33.3) 15 (31.3)
 1 7 (29.2) 9 (18.8)
 2 3 (12.5) 10 (20.8)
 3 6 (25.0) 14 (29.2)
T1 n (%) 0.422
 0 0 (0.0) 0 (0.0)
 1 4 (16.7) 15 (31.3)
 2 10 (41.7) 19 (39.6)
 3 9 (37.5) 14 (29.2)
T1 facet n (%) 0.705*
 0 10 (41.7) 25 (52.1)
 1 8 (33.3) 10 (20.8)
 2 4 (16.7) 8 (16.7)
 3 2 (8.3) 5 (10.4)
T2 n (%) 0.334*
 0 1 (4.2) 1 (2.1)
 1 7 (29.2) 24 (50.0)
 2 11 (45.8) 15 (31.3)
 3 4 (16.7) 8 (16.7)
T2 facet n (%) 0.916*
 0 16 (66.7) 28 (58.3)
 1 5 (20.8) 13 (27.1)
 2 3 (12.5) 6 (12.5)
 3 0 (0.0) 1 (2.1)
L1 n (%) 0.042*
 0 2 (8.3) 5 (10.4)
 1 2 (8.3) 13 (27.1)
 2 13 (54.2) 11 (22.9)
 3 6 (25.0) 18 (37.5)
L1 facet n (%) 0.277*
 0 14 (58.3) 16 (33.3)
 1 3 (12.5) 12 (25.0)
 2 1 (4.2) 5 (10.4)
 3 5 (20.8) 14 (29.2)
L2 n (%) 0.772
 0 5 (20.8) 15 (31.3)
 1 7 (29.2) 15 (31.3)
 2 8 (33.3) 12 (25.0)
 3 3 (12.5) 5 (10.4)
L2 facet n (%) 0.357*
 0 18 (75.0) 31 (64.6)
 1 5 (20.8) 8 (16.7)
 2 0 (0.0) 3 (6.3)
 3 0 (0.0) 5 (10.4)
Total body score, mean (SD) 25.4 (8.4) 29.9 (9.0) 0.044

Statistical significant p-values are given in bold.

*Fisher’s exact test.

NP, neuropathic pain; OACT, OsteoArthritis CT.